No profile data available.
Dogwood Therapeutics, Inc. (DWTX) is a healthcare company in the bone and joint treatment drugs industry, based in Alpharetta, United States, with about 8 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$35.51 million. Its market capitalization was $47.59 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.
Dogwood Therapeutics reported $0 in revenue for fiscal year 2025.
$47.59 million as of October 9, 2026.
Listed companies of a similar size in the same industry (bone and joint treatment drugs) include Eupraxia Pharmaceuticals Inc. (EPRX), Entera Bio Ltd. (ENTX), Mereo BioPharma Group plc (MREO), Enlivex Therapeutics Ltd. (ENLV).